12/26
11:42 am
auph
Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Low
Report
Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
12/16
04:03 pm
auph
Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms [Seeking Alpha]
Low
Report
Aurinia Pharmaceuticals: Silencing Doubters, But Competition Looms [Seeking Alpha]
12/16
10:12 am
auph
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors [Yahoo! Finance]
Low
Report
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors [Yahoo! Finance]
12/16
10:12 am
auph
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors [Globe and Mail, The (Toronto, Canada)]
Low
Report
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors [Globe and Mail, The (Toronto, Canada)]
12/15
03:42 am
auph
Assessing Aurinia Pharmaceuticals After Its 80% 2025 Surge and Lupus Nephritis Momentum [Yahoo! Finance]
Low
Report
Assessing Aurinia Pharmaceuticals After Its 80% 2025 Surge and Lupus Nephritis Momentum [Yahoo! Finance]
12/3
08:05 am
auph
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was given a new $16.00 price target on by analysts at Leerink Partners.
Medium
Report
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was given a new $16.00 price target on by analysts at Leerink Partners.
11/30
06:22 pm
auph
A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge [Yahoo! Finance]
Low
Report
A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge [Yahoo! Finance]
11/19
04:45 pm
auph
First Look at Roche/Genentech's Gazyva Shows Strong Early Enthusiasm in Lupus Nephritis Launch, According to Spherix Global Insights [Yahoo! Finance]
Low
Report
First Look at Roche/Genentech's Gazyva Shows Strong Early Enthusiasm in Lupus Nephritis Launch, According to Spherix Global Insights [Yahoo! Finance]
11/11
07:16 pm
auph
Longtime FDA oncology leader named agency's top drug regulator [CNN]
Low
Report
Longtime FDA oncology leader named agency's top drug regulator [CNN]
11/11
06:26 pm
auph
Longtime FDA oncology leader named agency's top drug regulator [CNN]
Low
Report
Longtime FDA oncology leader named agency's top drug regulator [CNN]
11/8
07:05 pm
auph
Results: Aurinia Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]
Low
Report
Results: Aurinia Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]
11/7
08:07 am
auph
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock, up previously from $10.00.
Low
Report
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock, up previously from $10.00.
11/6
06:56 am
auph
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was downgraded by analysts at Bloom Burton from a "moderate buy" rating to a "hold" rating.
Medium
Report
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) was downgraded by analysts at Bloom Burton from a "moderate buy" rating to a "hold" rating.
11/5
08:04 am
auph
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $15.00 price target on the stock.
Low
Report
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $15.00 price target on the stock.
11/4
06:00 am
auph
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress
Medium
Report
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress
11/3
06:00 am
auph
Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025
Low
Report
Aurinia Pharmaceuticals to Report Financial Results for the Three and Nine Months Ended September 30, 2025 and Provide Update on Recent Business Progress on November 4, 2025
11/1
08:27 am
auph
Is There An Opportunity With Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) 49% Undervaluation? [Yahoo! Finance]
Low
Report
Is There An Opportunity With Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) 49% Undervaluation? [Yahoo! Finance]
10/24
12:16 pm
auph
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
10/15
06:00 am
auph
Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025
Low
Report
Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025
10/11
12:41 am
auph
Does Aurinia's Latest Share Spike Reflect Its True Value After Recent Pipeline Updates? [Yahoo! Finance]
Low
Report
Does Aurinia's Latest Share Spike Reflect Its True Value After Recent Pipeline Updates? [Yahoo! Finance]
9/29
08:27 pm
auph
Aurinia Responds to Now Retracted LinkedIn Post
Medium
Report
Aurinia Responds to Now Retracted LinkedIn Post